comparemela.com

Latest Breaking News On - Mynd life sciences inc - Page 3 : comparemela.com

MYND Life Sciences Announces Collaborative Research Agreement with the University of British Columbia

/PRNewswire/ - MYND Life Sciences Inc. ("MYND" or the "Company") (CSE: MYND) (OTC: MYNDF) a biopharmaceutical research and development company creating.

South australiaUnited kingdomBritish columbiaChahaat singhWilfred jefferiesLyle obergMonash universityUniversity of british columbiaCollaborative research agreement theHealth canadaCollaborative research agreementLife sciences incNovel therapiesNeurological diseasesCentral nervous systemDrug act

MYND Life Sciences Acquires Rights for the Use of Psychedelics to Treat Alzheimer s Disease and other Dementias

/PRNewswire/ - Further to news release of October 27, 2021, MYND Life Sciences Inc. ("MYND") (CSE: MYND) (OTC: MYNDF) is pleased to announce it has.

United statesUnited kingdomBritish columbiaTheo warkentinLyle obergCava healthcare incWorld health organizationAlzheimer associationCanadian securities exchangeLife sciences incCava healthcareAcquired assetsMynd life sciences inc

MYND Life Sciences Acquires Rights for the Use of Psychedelics to Treat Alzheimer s Disease and other Dementias

/PRNewswire/ - Further to news release of October 27, 2021, MYND Life Sciences Inc. ("MYND") (CSE: MYND) (OTC: MYNDF) is pleased to announce it has.

United statesUnited kingdomBritish columbiaTheo warkentinLyle obergCava healthcare incWorld health organizationAlzheimer associationCanadian securities exchangeLife sciences incCava healthcareAcquired assetsMynd life sciences incMedical pharmaceuticalsHealth care amp hospitalsErgers and takeovers

MYND Life Sciences Provides Update on Depression Gene Modulation Pathway Patent Application

/PRNewswire/ - MYND Life Sciences Inc. ("MYND" or the "Company") (CSE: MYND) (OTC: MYNDF) is pleased to announce it has completed the National Phase filing of.

British columbiaLyle obergFinancial ltdWorld health organizationCanadian securities exchangeNational phaseLife sciences incPatent cooperation treatyImmune modulationSpecific geneIntellectual propertyInnovative new drugDepressive disorderTreatment resistant depressionHybrid financialMynd life sciences inc

MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation

/PRNewswire/ - MYND Life Sciences Inc. ("MYND" or the "Company") (CSE: MYND) (OTC: MYNDF) is pleased and extremely grateful to acknowledge the financial.

British columbiaWilfred jefferiesLyle obergLife sciencesLife sciences incNational research councilCanada industrial research assistance programCentral nervous systemChief science officerMynd life sciences inc

vimarsana © 2020. All Rights Reserved.